Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Susceptibility-Guided Sequential Therapy Versus Empirical Therapy for Helicobacter Pylori Infection: a Randomised Controlled Trial

NCT05549115 is registered in ClinicalTrials.gov with Liaocheng People's Hospital as lead sponsor.

NCT NCT05549115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05549115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Susceptibility-Guided Sequential Therapy Versus Empirical Therapy for Helicobacter Pylori Infection: a Randomised Controlled Trial
Lead sponsor
Liaocheng People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
September 20, 2022
Completion date
February 29, 2024
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection